IL2RA and B-cell chronic lymphocytic leukemia: Elevated plasma CD25 levels in patients with CLL suggest an activated state of malignant cells, as the increased CD25 expression in patients with CLL is associated with more aggressive disease characteristics, such as a rapid disease progression, and a poorer prognosis [32].